Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer.
OBJECTIVE
To describe comorbidities in breast cancer patients at diagnosis and examine factors associated with self-reported comorbidities 30 months post-diagnosis.


METHODS
Nine hundred forty one of 1,171 women had a medical record abstract and a follow-up survey in the Health, Eating, Activity and Lifestyle Study.


RESULTS
We compared our breast cancer cohort to a contemporaneous nationally-representative sample of age, race/ethnicity and education matched women without cancer (n = 865). Breast cancer patients did not have substantially more comorbidities than women without breast cancer. Women with a hospital record of congestive heart failure significantly less often received chemotherapy or radiation following breast conserving surgery. In multivariate analysis, women who received chemotherapy alone (OR = 3.2; 95% CI: 1.5-6.8), chemotherapy plus radiation (OR = 1.9; 95% CI: 1.02-3.7) or radiation plus tamoxifen (OR = 1.9; 95% CI: 1.1-3.2) were significantly more likely to report at least one new comorbid condition following breast cancer diagnosis than women who received no chemotherapy, tamoxifen or radiation. Overall, women who received adjuvant therapy were more likely to have new comorbidities.


CONCLUSIONS
Comorbidities were not substantially different in breast cancer patients than the non-cancer matched controls. Future research should focus on efforts to minimize comorbidities related to chemotherapy and other combination therapy.
Harlan
Linda C
LC
Applied Research Program, National Cancer Institute, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892, USA. lh50w@nih.gov
Klabunde
Carrie N
CN
Ambs
Anita H
AH
Gibson
Todd
T
Bernstein
Leslie
L
McTiernan
Anne
A
Meeske
Kathleen
K
Baumgartner
Kathy B
KB
Ballard-Barbash
Rachel
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000473:pathology / Q000628:therapy*; D016022:Case-Control Studies; D015897:Comorbidity; D005260:Female; D005705:Gallbladder Diseases / Q000175:diagnosis / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000453:epidemiology; D015141:Los Angeles / Q000453:epidemiology; D008875:Middle Aged; D009367:Neoplasm Staging; D009516:New Mexico / Q000453:epidemiology; D013959:Thyroid Diseases / Q000175:diagnosis / Q000453:epidemiology; D014861:Washington / Q000453:epidemiology